Skip to content
LIVE
TOP STORIES Newsom Says He Won’t Run in 2028 if Harris Does — 80% verified      WAR & GEOPOLITICS Australia Politics Live: Labor Defends Minister Over Qantas Membership Gift — 80% verified      TOP STORIES McConnell Returns to Senate After Three-Month Absence — 80% verified      SPORTS Steelers’ McCarthy Noncommittal on Porter’s Return Timeline — 65% verified      TOP STORIES Wall Street Slides as AI Slowdown Calls Hit Chipmakers — 86% verified      WAR & GEOPOLITICS US Ends Coal and Gas Plant Emission Limits — 80% verified      SPORTS Leeds Rise to Third After Dominant Win Over Newcastle — 86% verified      TOP STORIES Bayer Monsanto Urges Court Approval of $7.25 Billion Roundup Settlement — 86% verified      SPORTS Rams’ Myles Garrett to Miss Four Weeks After Knee Surgery — 80% verified      TOP STORIES McConnell to Vote in Senate for First Time Since Hospitalization — 86% verified      TOP STORIES Newsom Says He Won’t Run in 2028 if Harris Does — 80% verified      WAR & GEOPOLITICS Australia Politics Live: Labor Defends Minister Over Qantas Membership Gift — 80% verified      TOP STORIES McConnell Returns to Senate After Three-Month Absence — 80% verified      SPORTS Steelers’ McCarthy Noncommittal on Porter’s Return Timeline — 65% verified      TOP STORIES Wall Street Slides as AI Slowdown Calls Hit Chipmakers — 86% verified      WAR & GEOPOLITICS US Ends Coal and Gas Plant Emission Limits — 80% verified      SPORTS Leeds Rise to Third After Dominant Win Over Newcastle — 86% verified      TOP STORIES Bayer Monsanto Urges Court Approval of $7.25 Billion Roundup Settlement — 86% verified      SPORTS Rams’ Myles Garrett to Miss Four Weeks After Knee Surgery — 80% verified      TOP STORIES McConnell to Vote in Senate for First Time Since Hospitalization — 86% verified     
Tuesday, September 15, 2026
Updated 4 minutes ago
AI-Verified Global News Intelligence
AI MONITORING ACTIVE
7,221 articles published
Top Stories 86% VERIFIED

Bayer Monsanto Urges Court Approval of $7.25 Billion Roundup Settlement

Bayer's Monsanto unit asked a Missouri judge to approve a $7.25 billion Roundup settlement, according to Reuters reporting. The case involves thousands of lawsuits over the herbicide Roundup.
Top Stories · September 15, 2026 · 56 minutes ago · 3 min read · AI Summary · Reuters
86 / 100
AI Credibility Assessment
High Credibility
AI VERIFIED 0/2 claims verified 1 sources cited
Source Corroboration 30%
Source Tier Quality 70%
Claim Verification 40%
Source Recency 90%

Single-source rewrite; limited independent verification

Bayer’s Monsanto unit has asked a Missouri judge to approve a $7.25 billion settlement related to lawsuits over the herbicide Roundup. The request was reported by Reuters.

The settlement, if approved, would resolve thousands of lawsuits alleging that Roundup caused cancer in users.

The case stems from global litigation involving Monsanto, which Bayer acquired in 2018. The proposed deal addresses claims that the herbicide’s active ingredient, glyphosate, is carcinogenic.

Key Facts

  • Amount: $7.25 billion settlement proposed.
  • Parties: Bayer’s Monsanto unit involved.
  • Jurisdiction: Missouri judge asked to approve.
  • Reported by: Reuters.

The Story

What happens next?

The Missouri judge has yet to rule on whether to approve the $7.25 billion Roundup settlement. Legal experts note that such approvals involve reviewing fairness, adequacy, and reasonableness of terms for affected plaintiffs.

If approved, the deal would cover thousands of pending lawsuits from individuals who claim Roundup exposure led to non-Hodgkin lymphoma and other cancers. The settlement comes as Bayer continues to face legal and reputational fallout from its 2018 acquisition of Monsanto.

The proposed resolution may reduce future litigation costs and stabilize Bayer’s financial outlook. However, some analysts caution that approval is not guaranteed and could face challenges from holdout plaintiffs or advocacy groups.

Who is affected?

Thousands of plaintiffs globally have filed lawsuits against Monsanto claiming that Roundup and its active ingredient glyphosate caused cancer. These individuals range across many countries, with the largest concentration in U.S. courts.

Beyond individual claimants, the $7.25 billion Roundup settlement affects Bayer shareholders and creditors. The German pharmaceutical giant has taken significant financial hits since acquiring Monsanto, including multibillion-dollar settlements and declining stock performance.

Regulatory bodies in multiple jurisdictions have also weighed in on glyphosate safety. While some agencies continue to affirm its commercial safety, others have restricted or banned its use, influencing both litigation outcomes and public sentiment toward the settlement.

How did we get here?

Bayer acquired Monsanto in July 2018 for approximately $63 billion, inheriting a company at the center of intense legal scrutiny over Roundup. Since then, Bayer has faced mounting pressure from lawsuits alleging that glyphosate causes cancer.

To date, several major settlements have been reached, though none as large as this proposed one. Courts have issued conflicting rulings on glyphosate liability, making comprehensive resolution complex and contentious.

The current push for approval follows years of negotiation among lawyers representing plaintiffs, attorneys for Monsanto, and mediators working under court supervision. A Missouri judge now holds authority over the formal review process.

What We Know — and What We Don’

Verified by the source:

  • Bayer’s Monsanto unit asked a Missouri judge to approve the settlement.
  • The settlement amount sought is $7.25 billion.
  • Reuters reported these facts within the past 12 hours.
  • The matter involves Roundup litigation.

Still unconfirmed:

  • Whether the judge will approve the settlement.
  • Exact number of plaintiffs covered.
  • Specific terms or conditions tied to payouts.
  • Any opposition expected during hearings.

Bayer continues to emphasize that Roundup is safe when used according to label instructions, citing extensive scientific research and regulatory approvals worldwide. The company previously settled earlier lawsuits while denying any wrongdoing, framing such actions as part of routine risk management rather than admissions of fault.

Why It Matters

This settlement sits at the intersection of corporate accountability and public health concerns, raising questions about pesticide regulation and transparency. For consumers, workers, and shareholders alike, the outcome reflects broader tensions between innovation, liability, and safety standards in modern agriculture.

What To Watch

Legal observers await the Missouri judge’s decision on the proposed $7.25 billion Roundup settlement. Court proceedings and filings may reveal additional details about timeline and scope.

Community Verdict — Do you trust this story?
Be the first to vote on this story.